TNFRSF4 and Alzheimer disease: Studies have shown that the binding of OX40 and OX40L has an essential effect on T cell differentiation, and the targeting of OX40/OX40L in the treatment of AD is currently a hot research topic (Elieh Ali Komi and Grauwet, 2018).